CCL25-based tissue regeneration for the treatment of osteoarthritis
CCL25 (C-C motif chemokine ligand 25) was identified as a potent biological attractant for mesenchymal stromal cells at Charité – Universitätsmedizin, Berlin. Mesenchymal stromal cells are well known for their anti-inflammatory and tissue regenerative properties. However, production and transplantation of cells are expensive and require complex logistics. Application of chemokines for local recruitment of endogenous MSCs towards degenerated tissue could be a cost-effective alternative.